GBC AG: Aspermont Ltd. | Rating: Buy

Classification of GBC AG to Aspermont Ltd.

Company Name:	Aspermont Ltd.
ISIN:	AU000000ASP3
Reason for the research:	Research Report (Note)
Recommendation:	Buy
Last rating change:	0.07 AUD
Analyst:	Julien Desrosiers, Matthias Greiffenberger

Resurgence in Growth Following Challenging 2024 Half-Year Results. Strategic Recruitment of Renowned Top Executives and Leadership. Forecast Prioritizes Quality Revenue.

Rebound After a Challenging H1 2024: Despite early setbacks, Aspermont capitalized on its strategic investments in high-growth sectors to achieve a strong performance turnaround.

Strong Cash Position: The company maintains a healthy net liquidity of $1.3 million as of Q3 2024.

Year-on-Year Revenue Growth: Total revenue for Q3 2024 rose to $5.0 million, marking a 20% increase compared to the previous year.

Competitive Advantage: While competitors have faced significant losses in recent quarters, Aspermont's robust performance underscores its position of strength.

Operational Agility: Aspermont’s decentralized structure and scalable workforce continue to be key strengths, enabling swift product launches while managing investment risks, as evidenced by the increase in net asset liquidity.

Completing technological turnaround: The company will be shifting from revenue quantity to revenue quality in order to reach net profit equilibrium and start posting posting profits in FY2025.

Based on our DCF model, we revise our price target to AUD 0.03 / 0.02 EUR per share (down from AUD 0.07) and maintain a buy rating.

You can download the research here: http://www.more-ir.de/d/30985.pdf

Contact for questions:
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
https://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date and time of completion of this research: 02.10.2024 (03:00 pm)
Date and time of first distribution: 04.10.2024 (10:00 am)